A combination medicine that effectively manages the symptoms of allergic rhinitis such as runny & stuffed nose. Demonstrates a substantial reduction in allergic symptoms including, rhinorrhea, nasal congestion, nasal itching, and sneezing than montelukast-levocetirizine in patients with allergic rhinitis. (Mohini Sachin Mahatme, 2016) More effective agent than antihistaminic alone in the control of allergic rhinitis symptoms. (Mohini Sachin Mahatme, 2016) Has a dual mechanism of action and acts both as a bronchodilator and anti-inflammatory agent. (Mohini Sachin Mahatme, 2016) A safe and effective drug in the treatment of autumnal seasonal allergic rhinitis. (T B Casale, 1999) Significantly more effective than loratadine in relieving itchy, watery, red eyes symptoms and nasal congestion of seasonal allergic rhinitis patients. (P Van Cauwenberge, 2000)

An antivertigo drug that is used in the management of vertigo and vestibular pathologies of different aetiologies. (Lacour, 2013) Significantly effective in preventing/reversing the hearing deterioration in patients with Meniere’s disease. (Seyed Javad Seyed Tootoonchi, 2016) Exerts a positive effect in terms of reduction in vertigo symptoms. (Louisa Murdin K. H., 2016) An effective therapy for Meniere’s disease and related conditions. (Van Esch B, 2020) Improves the symptoms related to Meniere’s disease, such as vertigo sensation. Effectively reduces the pressure and ameliorates the blood flow to certain areas within the inner ear. (Deborah A Hall, 2018) Reduces the frequency and severity of vertiginous episodes, hearing loss, and tinnitus. (Cochrane ENT Group, 2001) Arrests the progression of hearing loss in patients with Meniere’s syndrome. (Cochrane ENT Group, 2001) An effective and safe option for the treatment of peripheral vertigo. (Rubén Ramos Alcocer, 2015)

A pain reliever medicine that is used for the short-term treatment of pain, especially post-operative pain and fever. A well-known, first-line, effective antipyretic and analgesic agent. (Elizabeth Chiam, 2015) Prevents the release of certain chemical messengers that cause pain and fever. Provides a rapid decline in body temperature. (D H Kett, 2011) Has a faster onset of action, greater analgesic efficacy, and a longer duration of action. An effective analgesic that is useful in a broad range of clinical conditions. (Chhaya V Sharma, 2014) Possesses similar analgesic properties as dexketoprofen in migraine and musculoskeletal trauma treatment.(Atakan Yilmaz, 2019), (Ibrahim Turkcuer, 2014) The best pain relief therapy in postoperative settings. (Keith A Candiotti, 2010) Offers satisfactory analgesia and reduces the consumption of opioids. (Uppal, 2011) A first-line agent for the treatment of pain and fever in adults and children. (Sean T Duggan, 2009) A well-tolerated drug that offers rapid and effective analgesia in patients with moderate to severe pain after orthopedic surgery. (Raymond S Sinatra, 2005)

A combination of a cough suppressant, a decongestant, antihistamine that treats symptoms of an allergy, cold, sinus inflammation, and cough. Efficacious as well as a safe treatment for allergic rhinitis. Blocks the effects of histamine, and relieves symptoms of allergies. Provides optimum symptomatic relief in allergic rhinitis patients. Effective in reducing the frequency of cough. Helps relieve congestion or stuffiness in the nose. Lowers the cough intensity. The most widely used antitussives for the treatment of cough associated with acute upper respiratory tract infection. (Lee PCL, 2000)

Belongs to a group of medicines called anti-anemic agents that replenishes the iron stores in the body. Significantly increases ferritin and hemoglobin concentrations and efficiently raises the iron stores. A well-tolerated, high compliance agent and more efficiently increases hemoglobin levels in iron-deficient anemic pregnant women than ferrous glycine sulfate. (Ahmed M Abbas, 2019) Shows a rapid rate of hemoglobin synthesis. (Ching-Tzu Lee, 2016) An effective alternative treatment in patients with iron deficiency anemia. A safe and effective treatment option for iron deficiency and anemia. Improves overall zinc status better than other zinc supplements. Restores B12 levels in the body and prevents the complications associated with vitamin B12 deficiency. Helps in treating certain anemias and nerve problems. A useful therapeutic agent for the production of red blood cells and treats megaloblastic anemia caused by vitamin B12 deficiency. Provides a higher increase in hemoglobin level (2.48 g/dL) than ferrous glycine sulfate (1.32g/dL). (Ahmed M Abbas S. A., 2019)

A medication that addresses liver and bile duct pathologies. (Krupa) A potent farnesoid X receptor agonist for the treatment of liver diseases namely, primary biliary cholangitis. (Bethesda) Suppresses bile acid synthesis in the liver and hepatic damage caused by primary biliary cholangitis. (Susan M. Smith, 2017) Protects against the toxic accumulation of bile acids in the liver and facilitates hepatic regeneration. (Palak J Trivedi, 2016) Exerts significant anti-inflammatory, anti-fibrotic activities, and inhibits the processes of liver inflammation. (Ludovico Abenavoli, 2018) Lessens the markers of liver inflammation and fibrosis in patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease. Provides an effective therapeutic option for patients with primary biliary cholangitis in the absence of ursodeoxycholic acid. (Kris V. Kowdley, 2018) Reduces serum alkaline phosphatase in patients with primary sclerosing cholangitis. Represents a promising treatment for patients with nonalcoholic fatty liver disease. (Evangelia Makri, 2016) The most potent farnesoid X receptor agonist with about 100‐fold greater potency than chenodeoxycholic acid. (Yuanyuan Zhang, 2017) An alternative treatment for patients who are unable to tolerate ursodeoxycholic acid with primary biliary cholangitis. (Susan M. Smith, 2017) Reduces elevated levels of alkaline phosphatase (ALP), γ-glutamyl transpeptidase (GGT), and alanine aminotransferase (ALT), in patients with primary biliary cirrhosis who had inadequate responses to ursodeoxycholic acid. (Gideon M Hirschfield, 2015)

Bisoprolol is indicated for the treatment of mild to moderate hypertension. A beta-blocker is used primarily for the management of cardiovascular conditions. (Huda Mohammed Alkreathy, 2020) Enhances cardiac output by reducing cardiac workload and oxygen demand. (Jane K McGavin, 2002) Lowers blood pressure to reduce the risk of heart attacks and strokes. Decreases the risk of death from heart-related issues in patients with heart failure & reduces heart function (low ejection fraction). (Marco Metra, 2007) Helps manage heart failure by improving heart pumping efficiency. A potent well-tolerated effective, and safe option for long-term hypertension management. (H Lithell, 1987) Effectively lowers both systolic and diastolic blood pressure throughout the day. (Eguchi, 2016) Improves heart function in patients with angina by supporting better blood flow. (Eguchi, 2016) An effective alternative to other beta-adrenoceptor antagonists in patients with mild to moderate essential hypertension or stable angina pectoris. (S G Lancaster, 1988)

An anti-anginal agent that is used for the prophylaxis against angina pectoris mainly due to heart blockage. A potent vasodilatory drug that helps in dilating and relaxing the blood vessels of the heart. (Abrams, 1983) Provides effective, well-tolerated therapy for patients with cardiovascular disease. (Abrams, 1983) Prevents and aborts an acute angina attack, and improves the quality of a patient’s life. (William E Boden S. K., 2015) Relaxes the blood vessels and increases the supply of blood and oxygen to the heart while reducing its workload. (Abrams, 1985) An effective prophylactic drug that causes vasodilation and increases blood flow to the heart. (Julio C.B. Ferreira, 2012). A first-line treatment for angina pectoris and acute myocardial infarction. (Julio C.B. Ferreira, 2012) The treatment of choice for relieving angina due to rapid action and its established efficacy. (N Marsh, 2000) Reduces myocardial oxygen requirements through decreases in left ventricular preload and afterload. (Abrams, 1985) An effective, convenient, and generally safe therapeutic option for alleviating anginal episodes. (William E Boden, 2015)

A diuretic medication is commonly used to treat several conditions, primarily related to cardiovascular health and fluid retention. Lowers blood pressure by removing excess fluid from the body and relaxing blood vessels. Reduces the workload on the heart and decreases the risk of stroke, heart attack, and kidney problems. Effectively controls blood pressure by inducing diuresis, thus reducing intravascular volume. (Kerndt, Patel, & Patel) An effective agent in treating edema associated with congestive heart failure, cirrhosis of the liver, and renal dysfunction. The preferred choice among thiazide-type diuretics for managing hypertension in patients at elevated risk of cardiovascular events. (Michael P Dorsch, 2011) Significantly effective in maintaining lower blood pressure consistently throughout the day and night. (Anil K Pareek, 2016) Provides better cardiovascular risk reduction due to its longer duration of action and greater antihypertensive efficacy than hydrochlorothiazide. (Vítor Magnus Martins, 2019) A better diuretic that demonstrates superiority over hydrochlorothiazide in both antihypertensive effectiveness and cardioprotection. (S G Chrysant, 2021)

A combination of statin and antiplatelet for the treatment of patients with various cardiovascular disorders such as heart attacks and strokes. A safe and effective 3-hydroxy-3-methyl-glutaryl-CoA (HMG-CoA) reductase inhibitor that lowers low-density lipoprotein (LDL) and total cholesterol levels. (Wierzbicki, 2001) Blocks platelets from sticking together by inhibiting the adenosine diphosphate receptor and prevents them from forming harmful clots. (Manuel Rodríguez-Yáñez, 2011) An effective anti-platelet agent used to treat and prevent a variety of thrombotic diseases. (Dawn S. Kuszynski, 2022) More effective than that of Atorvastatin (10 mg) and acetylsalicylic acid (300 mg) in inhibiting ADP-mediated platelet aggregation and expression of major platelet receptors after coronary artery bypass grafting. (Sermin Tetik K. A.-D., 2010) Provides greater platelet inhibition than acetylsalicylic acid and atorvastatin therapy after coronary artery bypass grafting. (Sermin Tetik, 2010) Shows an improved platelet inhibition compared to clopidogrel given alone in patients with ischemic heart disease. (Sermin Tetik, 2010) Produces greater low-density lipoprotein and triglyceride reductions than other statins due to its long-lasting action. (Roxana Sadeghi, 2014)

An anti-seizure medication that is used for treatments for migraine, bipolar, mood, and anxiety disorders. (Rahman & Nguyen.) A broad-spectrum antiepileptic drug that is effective against many different types of epileptic seizures. (Friis, 1998) Prevents epileptic fits by stabilizing excessive electrical activity in the brain. Possesses anti-epileptic, mood-stabilizer, and neuroprotective properties. (Michele Romoli, 2019) A promising therapeutic agent in treating bipolar mood disorder, targeting symptoms of irritability, aggression, and impulsivity. (Rahman & Nguyen, Valproic Acid) Has the broadest spectrum of anticonvulsant action compared to all currently available antiepileptic drugs in patients suffering from epilepsy. (Michele Romoli, 2019) An alternative treatment for patients who generally respond less well to lithium or as a useful adjunct in the treatment of complicated patients who do not respond to single agents. (C Lennkh, 2000) A well-tolerated and effective agent in bipolar disorder. (C Lennkh, 2000) Effectively reduces depressive symptoms of acute bipolar depression. (LA Smith) An effective drug for the prophylactic treatment of mood and psychotic disorders, particularly the manic phase of bipolar disorder and schizoaffective disorder. (S L McElroy, 1989)

A combination drug [antibiotic & antifungal] that fights vaginal infections in women. Effectively prevents vaginal discharge, itchiness, foul odor, and swelling in the genitourinary area. A potent antifungal agent against Candida species as well as effective against Trichomonas vaginalis. (Manish Maladkar, 2015) The preferred antimicrobial agent for serious infections of the female genital tract. (Zambrano, 1991) A safe and effective option in the treatment of bacterial vaginosis. (Hoz, 2021) An effective and well-tolerated medication for the treatment of mixed vaginosis due to bacterial and fungal origin. The addition of clotrimazole to clindamycin widens the spectrum of antibacterial action. (Manish Maladkar S. P., 2015) An alternative therapy to metronidazole for the treatment of bacterial vaginosis. (Marek Smieja, 1998) Demonstrates higher clinical cure rate [97.29%] and microbiological cure rate [93.24%] than with nifuratel-nystatin combination [93.15%] and [87.67%] respectively in patients with bacterial vaginosis. (Hoz, 2021)

A topical hair restoration agent is used for the treatment of hair loss. A trichogenic agent that stimulates the hair follicle. (DeVillez, 1990) A therapeutic agent that slows or stops hair loss and promotes hair regrowth. (Alfredo Rossi, 2012) Increases the blood circulation to hair follicles and promotes the growth of new hair. Enhances hair growth by prolonging the anagen phase and induces new hair growth in androgenetic alopecia individuals. (Hyeon Gyeong Yoo, 2007) A beneficial treatment modality for patients with alopecia androgenetica. (S P Clissold, 1987) Demonstrates a statistically significant increase in hair counts and improves hair loss conditions. (Elise A Olsen, 2007) The first available medication with the potential to promote substantial hair regrowth in alopecia areata and alopecia androgenetica. (S P Clissold, 1987) Significantly superior to the lower-strength 2% formula in terms of hair regrowth and scalp coverage. (Elise A Olsen F. E., 2002)

An anti-inflammatory and spasmolytic drug relieves mild to moderate pain in the muscles associated with spasms. Alleviates gastrointestinal and genitourinary smooth muscle spasms. A highly potent spasmolytic agent with excellent smooth muscle relaxant properties. (S. A. Shah, 2011) Inhibits the release of certain chemical messengers that cause abdominal pain and inflammation. An effective candidate that eases spasmodic pain arising from smooth muscle diseases like irritable bowel syndrome, and intestinal, biliary, or ureteric colic. (Nijhawan, 2021) Possesses a good relaxing effect on intestinal smooth muscle, which assists in alleviating pain. (Ramesh R. Rai, 2014) A suitable, effective, and well-tolerated treatment option for primary dysmenorrhea. (Anil Pareek, 2010) Shows superior anti-inflammatory properties and an improved safety profile than conventional NSAIDs. (Vinod K M, 2013) A promising approach ameliorates post-operative pain associated with spasms and inflammation. (Vinod K M, 2013) Significantly more effective than aceclofenac alone in relieving postoperative pain following laparoscopic surgeries. (Vinod K M, 2013)